Skip to main content

Press

Interview with CEO Peter Wolpert

Latest report

2017-08-08 Interim report January – June 2017

Kontaktperson press och media:

Peter Wolpert, VD
Tel: +46 8 522 307 08
Email: peter.wolpert@mobergpharma.se
 

Subscribe

Get our latest press releases and reports

 

Calendar/presentations

Next calendar event: 2017-09-05 Redeye Investor After Work